https://www.selleckchem.com/pr....oducts/trastuzumab-d
31, 95% CI 1.51-6.77, P=0.005) and disease-free survival (DFS) (HR 2.73, 95% CI 1.34-5.47, P=0.007) in LARC patients. A low pretreatment AFR level was significantly associated with a poor 5-year OS and DFS by the Log rank test (P=0.003 and 0.006, respectively). Pretreatment AFR level was an independent prognostic factor in LARC patients undergoing TME after nCRT. Pretreatment AFR level was an independent prognostic factor in LARC patients undergoing TME after nCRT. The prognostic value of serum calcium levels in nasophary
Curtir
Comentario
Compartilhar
